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ABSTRACT 
 
The ends of human telomeric DNA consist of single-stranded overhangs of tandem 
TTAGGG repeats (ssTEL) that can form into a G-quadruplex (GQ). This guanine-rich sequence 
is prone to 8-oxoguanine (8OG) damage, which is one of the most common oxidative DNA lesions 
that can compromise telomere integrity.  Here, we use single molecule Förster Resonance Energy 
Transfer (smFRET) to characterize the effect of 8OG on the structural dynamics and accessibility 
of ssTEL.  We show that the stable GQ folding observed in ssTEL is disrupted by a single 8OG, 
generating dynamic conformational fluctuations of the DNA. Such structural dynamics induced 
by 8OG lead to increased binding of complementary DNA oligonucleotides, as well as faster and 
more effective association of a telomere binding protein, protection of telomeres 1 (POT1), 
suggesting enhanced accessibility of telomeric DNA to interacting molecules. The increased 
dynamics and accessibility caused by 8OG is comparable to the effect of a base substitution from 
G to C at the same position, which abolishes the Hoogsteen basepairing required for GQ folding. 
Our results suggest that a single 8OG in telomeric DNA can lead to destabilization of GQ folding, 
which may alter the processes that govern telomere maintenance and extension activity.   
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CHAPTER 1: INTRODUCTION 
 
1.1 Structure and Properties of G-quadruplex 
The structure of the G-quadruplex was first identified by Gellert et al. (1962) in order to 
determine why guanosine has the unusual physical property of being able to form gels readily in 
aqueous solution (1).  Based on diffraction patterns, they postulated that the guanosine 
monophosphate (GMP) gel fibers had a regular helical structure with a hydrogen bonding 
arrangement of four coplanar guanine bases, which act as both a donor and acceptor of two 
hydrogen bonds between each Hoogsteen G-G base pair.  They also predicted that these G-
quartet structure could stack on top of each other to form linear aggregates, which are now 
known as G-quadruplex (GQ) or G-tetraplex.   
Further studies revealed that monovalent cations are needed in the central cavity of GQs 
to complex with inwardly projecting carbonyl oxygens (guanine O6), in order to neutralize 
electrostatic repulsion (2, 3).  They determined that the binding capacity is size-specific, and 
calculated that Li+ is too small to form a complex, Na+ fits easily in the center of the plane, and 
that K+ is too large to fit in the plane, but can fit between two planar tetramers, thus promoting 
GQ stability most efficiently (4–6).   
Although the structure of GQ is primarily determined by the condensation of guanine 
residues around this monovalent cation, secondary effects such as base-stacking forces, hydrogen 
bonding, and hydrophobic effects determine the final structure (7).  As a result, the stability, 
kinetics, and conformation of GQ are very sensitive to multiple factors, such as ionic conditions, 
temperature, molecular crowding conditions, strand stoichiometry, and DNA length, sequence, 
arrangement, and concentration (4–6, 8–16).  Under these conditions, the structural 
polymorphism of GQ can be classified by molecularity: intramolecular (one strand) or 
intermolecular (two or more strands), strand orientation: anti-parallel, parallel, or hybrid 
(between anti-parallel and parallel), guanine glycosidic angles: syn or anti conformations, and 
loop orientation: lateral, diagonal, or propeller (17).  The strand orientation and guanine 
conformation are interrelated in that all parallel GQs have all guanine glycosidic angles in an 
anti conformation, while anti-parallel GQs have both syn and anti guanines (17).   
The structural polymorphism and folding pathways of various GQ structures are relevant 
to understanding the context and scope of GQ studies, and can be illustrated by the various 
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intramolecular GQ structures seen in human telomeric DNA (11–26).  This property has 
implications for the design of GQ binding ligands, which have potential in cancer therapeutics 
among many other applications.   
 
1.2 Evidence for Biological Functions of DNA G-quadruplex  
Two bioinformatics studies applying different algorithms concurrently reached similar 
conclusions of ~375,000 (27) and ~376,000 (28) candidate sequences with tracts of tandem 
guanines that may form intramolecular DNA GQs in the human genome.  Of these, 60% 
(~223,000) were found in intergenic regions, 40% (~151,000) within genes, and only ~14,000 
within exons (27).  Huppert & Balasubramanian (2005) also noted the significant repression of 
GQs in the coding strand of exons, and suggested that there may be evolutionary pressure to 
reduce the number of GQs allowed to form in mRNA (28).   
More detailed analyses in regulatory regions have shown that GQ motifs are concentrated 
in promoter regions with the frequency increasing closer to transcription start sites (29).  In fact, 
nearly half of all known genes in the human genome contain such putative GQ sequences within 
a 1,000 nucleotides upstream of transcription start sites (29).  Studies that correlated GQ 
formation with functional classes of genes found that promoters of housekeeping and tumor 
suppressor genes are under-represented in GQ motifs, while promoters of human oncogenes and 
regulatory genes (e.g., transcription factors) are over-represented (29, 30).  This suggests that 
genomic structure undergoes selection based on gene function, and that this may be a mechanism 
for global regulation of gene expression. 
Early in vivo studies focusing on single genes suggested the presence of GQ structures in 
important regulatory regions and postulated biologically relevant roles for these secondary 
structures.  Subsequent studies provided evidence supporting their hypotheses and also 
determined possible mechanisms for these biological functions.   
In the late 1980s, intramolecular GQs were found in single stranded telomeric DNA and 
were predicted to influence telomere functioning (31–33).  Since then, many studies have further 
studied telomeric GQ folding conformations and dynamics (11, 12, 18–26, 34) and provided 
evidence for the various roles of telomeric GQ in telomere maintenance.  One of the most well 
studied functions is the inhibitory effect of GQ on telomerase-based telomere lengthening (35).  
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This observation is the basis for development of GQ stabilizers as an anticancer therapeutic (36).  
The effect of GQ on telomeres will be discussed in further detail in later sections.   
Other early findings suggested the involvement of GQ in transcriptional regulation.  GQs 
were found in a regulatory region upstream of the insulin gene (37), the 5’ sequence of human 
and mouse retinoblastoma susceptibility genes (38), and a nuclease-hypersensitive element 
upstream of a promoter of the human c-MYC proto-oncogene (39, 40).  Siddiqui-Jain et al. 
(2002) studied the structure and function of GQ in this particular c-MYC promoter region, and 
found that it acts as a repressor of c-MYC transcription.  They showed that a GQ binding ligand 
suppresses c-MYC transcription, while a single point mutation that destabilizes the GQ structure 
results in a 3-fold increase in basal transcriptional activation (41).   
It is thought that GQ structures both positively and negatively regulate transcription (42).  
GQs on the template strand can inhibit transcription, while those on the non-template strand can 
enhance transcription by maintaining the transcribed strand in a single-stranded conformation.  
GQ-protein interactions may also modulate transcription, based on the nature of the protein.  
Genome-wide analysis of the effect of a GQ binding ligand found that expression levels of many 
genes were both up and down regulated (43).  Another genome-wide study investigated the 
effects of GQ unwinding helicases on transcription and determined that Werner’s syndrome 
(WRN) or Bloom’s syndrome (BLM) helicase deficiency significantly upregulates genes 
associated with GQ motifs, which account for 20-30% of genes upregulated (44).        
Various studies have also demonstrated the recombinogenic potential of GQ structures.  
Sen & Gilbert (1988) suggested that GQ is involved in synapsis during meiosis and that it is 
responsible for switch recombination at G-rich human immunoglobulin heavy-chain switch 
regions, which allows for antibody diversity (4).  Larson et al. (2005) then provided evidence for 
this by showing that MutSα, a DNA mismatch repair protein, binds with high affinity to GQ 
structures that form upon transcription of intronic, G-rich, and repetitive switch regions (45).  
This event then promotes DNA synapsis and activates switch recombination.  Another study in 
Neisseria gonorrhoeae found that a single GQ sequence in the recombination initiation sequence 
is necessary to promote antigenic variation of its surface epitopes (46).  They found that GQ-
disrupting mutations and GQ stabilization both prevented DNA nicks within the GQ region and 
blocked antigenic variation, which allows the pathogen to avoid detection by the host immune 
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system (46).  In a later study, they showed that inactivating the promoter of a small non-coding 
RNA that initiates within the GQ forming sequence, blocks antigenic variation (47).   
Homologous recombination (HR) is an important mechanism for double-stranded DNA 
break (DSB) repair in mammalian cells, and is also known to promote the restart and repair of 
stalled or broken replication forks (48).  Replication forks that stall at GQ motifs may become 
remodeled into recombination intermediates, which suggests that stalled replication or DNA 
breakage near GQs can be rescued by recombination (49, 50).   
The significant colocalization of GQ motifs with sites susceptible to breakage (51), 
implicates GQ structures in hindering transcription and replication (44), which are processes that 
require accessibility and readability of each base to faithfully transmit genetic information.  This 
is supported by evidence that GQ stabilizers induce DNA breaks and affect expression of genes 
that have GQs in their promoter regions (51–54), and by evidence that helicases prevent DNA 
damage by resolving GQ structures during DNA replication (44, 53, 55–57).   
Of note, human helicases that unwind GQ are associated with human diseases that cause 
genomic instability, including Werner’s syndrome (WRN), which is associated with premature 
aging, Bloom’s syndrome (BLM), which is associated with increased cancer risk, and Fanconi 
anemia (FANCJ) and PIF1, which are both also associated with predisposition to cancer (42, 58).  
Interestingly, these helicases can counter GQ barriers at replication forks, as well as repair DSBs 
(44, 53, 59–61), which highlights their importance for suppressing genome instability.   
London et al. (2008) provided strong evidence that human disease is associated with a 
loss of GQ unwinding by mapping the accumulation of large genomic deletions at GQ containing 
regions in a FANCJ-deficient human cell line (61).  Similarly, studies in Caenorhabditis elegans 
showed that mutation in the DOG-1 helicase, which is distantly related to FANCJ, causes 
genome-wide deletions in putative GQ forming sequences (62, 63).  Rodriguez et al. (2012) 
demonstrated that the GQ stabilizer, pyridostatin, bound preferentially to GQ motifs genome-
wide and caused replication and transcription-dependent DNA damage, which then induced 
growth arrest in human cancer cells.  They used chromatin immunoprecipitation sequence (ChIP-
Seq) analysis to detect high DNA damage marker (γH2Ax) content in regions with putative GQ 
sequences, which colocalized with PIF1 foci in pyridostatin-treated human cells.  Additionally, 
Koole et al. (2014)  also discovered a profound loss of GQ surrounding sequences in the absence 
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of the A-family polymerase Theta, which is necessary for a non-canonical DNA break repair 
mechanism that prevents genomic instability and replication fork barriers (64).  
The GQ barrier at the DNA replication fork may also interfere with the inheritance of 
epigenetic information.  The propagation of histone marks is thought to rely on local recycling of 
parental histones to nascent daughter DNA strands (65), and subsequent copying of the 
epigenetic state of the parental DNA to newly deposited histones, during DNA replication.  The 
lack of REV1 translesion polymerase causes genome-wide dysregulation of gene expression, 
which is correlated with altered histone marks nearby GQ motifs (66).  This suggests a 
disturbance in GQ-dependent transcription and maintenance of epigenetic integrity.  The effect is 
even more prominent when FANCJ, WRN, and BLM helicases are deficient (67, 68).   
Despite these studies, there has been debate as to whether these structures existed and had 
functional roles in living cells.  One of the first studies to provide direct evidence for the 
existence of GQ in vivo detected parallel telomeric GQs from a ciliate (Stylonychia lemnae) 
using antibody staining (69).  Another study that established GQ DNA formation in vivo was 
done by introducing a plasmid containing human telomeric repeat inserts in E.coli and inducing 
transcription in these living cells to observe the formation of intramolecular GQ DNA using 
electron microscopy (70).  Müller et al. (2010) also provided direct evidence for the existence of 
GQ in telomeric DNA by using a small molecule GQ binding ligand that targets telomeric GQ 
structures to pull down telomeric DNA (71).   
More recent studies have developed GQ specific antibodies and ligands to use them for 
visualizing GQ structures in human cells and for isolating GQ forming sequences from human 
genomic DNA.  Henderson et al. (2013) developed monoclonal antibodies specific for different 
GQ DNA structures and identified one that exhibited strong nuclear staining in mammalian cells 
(72).  They showed that nuclear staining intensity increased when cells were treated with GQ 
binding ligands or when they were deficient in FANCJ, which is a GQ DNA-specific helicase 
that unwinds GQ structures.  Lam et al. (2013) confirmed the existence and stability of GQ 
structures in human genomic DNA, by using another engineered antibody to pull-down GQ 
structures and conducting deep sequencing to detect and map GQ at a high resolution (73).  They 
found stable GQ structures in sub-telomeres, gene bodies, and gene regulatory regions, and 
showed that GQ stabilizing small molecules can modulate transcription in identified GQ 
containing genes.  Biffi et al. (2013) followed the formation of GQ structures during cell cycle 
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progression and found that it is formed during DNA replication, and is resolved when cellular 
processes are quiescent and no replication occurs (74).  They also applied pyridostatin to confirm 
that small molecule ligands interact directly with endogenous DNA and stabilize GQ structures 
(74), which may then lead to DNA damage if not resolved (54).   
Early studies suggesting the existence of DNA GQ structures in important regulatory 
regions were followed by findings that provided evidence for their biological relevance.  
Complementary bioinformatics studies revealed the non-random abundance of GQ motifs in 
these genomic regions, which include telomeres, oncogenic gene promoter regions, and 
recombination hotspots.  The existence of proteins that bind, cleave, resolve or promote 
formation of GQ has provided compelling evidence for the in vivo relevance of GQ.  Likewise, 
the discovery and development of GQ binding ligands and antibodies have allowed in vivo 
experiments to examine dysregulation of DNA processes by GQ stabilization, directly visualize 
GQ structures in cells, and isolate GQ forming sequences from genomic DNA.  In conclusion, 
DNA GQ structures have emerged as a significant player in telomere maintenance, 
transcriptional regulation, DNA recombination, DNA replication, DNA repair, and epigenetic 
regulation.   
 
1.3 Overview of Telomeres and their Processes 
In the 1930s, Hermann Müller and Barbara McClintock were the first to observe that 
chromosome ends were not prone to degradation, recombination, and end-to-end fusions (75, 
76).  Their cytogenetic studies were confirmed by Sandell & Zakian (1993), who used yeast 
strains to show that eliminating this protected end, coined telomere by Müller, resulted in RAD9-
mediated cell cycle arrest and a dramatic loss of telomeres (77).  They determined that telomeres 
prevent the ends from being recognized as double-stranded DNA breaks (DSBs) by DNA 
damage machinery.   
Studies in various eukaryotes found that telomeric DNA is highly conserved and share a 
common feature of GC rich tandem repeat sequences (78–83).  In vertebrates, telomeric DNA 
was determined to extend beyond the DNA duplex to form a terminal 3’ single-stranded G-
overhang (ssTEL) of varying lengths (84, 85).  In humans, the telomeric DNA consists of 5’-
TTAGGG-3’ hexameric repeats (83), and is about 150 to 200 nucleotides long (86, 87).   
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Telomeric DNA has been observed to adopt two different protective forms that sequester 
the ssTEL: the T-loop structure, where ssTEL folds back and invades into the double-stranded 
DNA (D-loop) (88), and the intramolecular G-quadruplex structure (GQ) (31, 32, 69).  These 
capping structures are thought to represent different functional states, but may not be mutually 
exclusive (16, 89).   
In addition to chromosome end protection, telomeres are involved in preventing 
important genetic information from being lost.  These non-coding repeat sequences serve as an 
expendable buffer that gets shortened with each round of DNA replication, which occurs due to 
the inability of DNA polymerase to completely replicate DNA ends.  This end-replication 
problem is resolved by a telomere lengthening mechanism (90, 91).   
The first to be discovered and garner a great deal of attention is a mode of telomere 
replication that involves telomerase.  Greider and Blackburn identified an enzyme in 
Tetrahymena ciliates that could synthesize tandem telomere repeats de novo using 
deoxynucleoside triphosphate substrates (dNTPs), without using ATP (78, 92).  They determined 
that the specialized ribonucleoprotein complex needed both its reverse transcriptase enzyme and 
RNA template (93, 94), and developed the telomerase elongation model where telomerase base 
pairs complementary sequences at the 3’ tail to its RNA template, adds a repeat sequence, 
translocates, and continues this process (75).   
However, telomerase is differentially expressed, and this is thought to contribute to 
heterogeneity in telomere length.  Observations of telomere length in different human tissues 
suggested that telomerase is active in germline cells, but not in somatic cells (75).  Normal 
somatic human cells progressively lose telomeres with each round of DNA replication until their 
telomeres reach a critically short length, the “Hayflick limit”, after which they respond by 
entering a senescent state (95, 96).  If they continue to divide they enter crisis, which leads to 
progressive chromosomal instability and apoptosis, as is seen in aging (91, 97, 98).   
Cancer cells overcome senescence and crisis, and hijack a telomere lengthening 
mechanism to acquire unlimited replicative potential, which enables them to divide indefinitely 
and transform into immortalized cells.  This immortalization is a critical step in tumorigenesis 
and is considered one of the hallmarks of cancer (99).   
Most cancer cells (~85%), typically carcinomas, do this by overexpressing telomerase 
(100).  Transformation of cells by oncogenes or ectopic expression of the human telomerase 
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reverse transcriptase (hTERT), both activated telomerase and stabilized telomere length to allow 
postsenescent cells to proliferate beyond crisis (101, 102).  These methods were used to directly 
convert normal human epithelial and fibroblast cells into cancer cells (103).  Conversely, 
inhibition of telomerase activity by expression of mutant telomerase was shown to reduce 
telomere length and cause death of tumor cells (104).  
By contrast, ~10-15% of cancers, which include many sarcomas and glioblastoma 
multiforme, were found to maintain telomere length by the alternative lengthening of telomeres 
(ALT) pathway (105), which involves recombination-mediated DNA replication (106–110).  
This form of DNA replication can be achieved by copying telomeric sequences between sister 
chromatids or by loop-mediated copying.  Dunham et al. (2000) showed that DNA sequences can 
be copied from telomere to telomere by homologous recombination and copy switching (109), 
while Muntoni et al. (2009) revealed that intra-telomeric DNA copying can also occur when 
primed by a t-loop structure (111).  The fact that human ALT cells have abundant telomeric 
circles, points to frequent t-loop homologous recombination events that can promote rolling 
circle replication of telomeres (112).  
Murnane et al. (1994) followed human ALT+ cells undergoing steady telomere attrition 
and then suddenly having a change in telomere length, which suggests recombination (113).  As 
a result, ALT+ cells are characterized by variable telomere lengths, which is in contrast to 
telomerase-positive cells that generally maintains a stable and homogeneous telomere length 
(108, 114).  Yeager et al. (1999) also discovered the ALT-associated PML bodies (APBs), which 
are large subnuclear complexes where PML bodies colocalize with telomeric DNA, telomeric 
binding proteins, and proteins involved in DNA synthesis and recombination, such as RAD51 
and RAD52 (115).  APBs are considered to be one of the hallmarks of the ALT mechanism and 
has been found to appear as soon as ALT is activated (115).  Additionally, ALT+ cells generate 
telomeres with variant repeat sequences due to recombination events with upstream subtelomeric 
sequences (116), and have telomeres that spontaneously elicit a DNA damage response (DDRs), 
but repress fusions (117).  Cesare & Reddel (2010) suggested that these telomeres can adopt 
three distinct states with various levels of chromosome end protection: a “closed-state” that 
represses DDRs and fusions, an “intermediate-state” that is susceptible to DDR but repress 
fusions, and an “uncapped” state that is susceptible to both (118).  They speculate that DSB 
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repair proteins localize to intermediate telomeres, but actively prevent fusions by shelterin 
proteins, most likely TRF2 and RAP1, which are known to inhibit these events. 
In mammals, the shelterin complex is essential for telomere regulation and protection, as 
well as control of signaling cascades from the chromosome ends.  It consists of six proteins: 
POT1 (protection of telomeres 1), TPP1 (POT1-interacting protein 1, formerly PIP1), TIN2 
(TRF1 interacting nuclear factor 2), TRF1 (telomeric repeat binding factor 1), TRF2 (telomeric 
repeat binding factor 2), and RAP1 (repressor/activator protein 1) (119).  In humans, the 
shelterin complex may interact with ~200 other telomere-associated proteins that may also 
influence telomeric structure (120).  Of the six proteins that make up the shelterin complex, 
POT1 protein binds specifically to ssTEL.  It forms a heterodimer with TPP1, which links it to 
the other shelterin proteins and to telomerase, and also with TRF2, which binds telomeric 
double-stranded DNA (121).   
The interaction between POT1 and TRF1 via TPP1 and TIN2, allows POT1 to transduce 
information about telomere length to the telomere terminus, where telomerase is regulated, and 
also allows TRF1 to regulate POT1 binding/loading on ssTEL in response to telomere length 
(122, 123).  Kendellen et al. (2009) reported that association of POT1 with TRF2 is also critical 
for telomere length homeostasis (124). 
In addition to being involved with regulating telomere length, POT1 binds to the 3’end of 
ssTEL to prevent unwanted DNA damage response (121, 125–133).  Its ssDNA binding domain 
dictates ssTEL recognition and is a conserved DNA-binding motif, known as an 
(oligonucleotide/oligosaccharide binding) OB-fold (134).  Lei et al. (2004) reported the crystal 
structure of the DNA binding domain of human POT1 (hPOT1) bound to the minimum binding 
sequence of 5’-TTAGGGTTAG-3’, which is about one and a half telomere repeats (135).  They 
revealed that two tandem OB folds pack together and form a continuous binding cleft.  The N-
terminal OB fold of hPOT1 binds to the first six nucleotides, while the second OB fold binds and 
protects the 3’ end of ssTEL.  Of note, the last nucleotide G10 is deeply buried in the binding 
pocket of the second OB fold, which may be involved in preventing access by telomerase (135).   
Studies of each OB fold in mouse paralogs, Pot1a and Pot1b, showed that both OB folds 
of POT1 are necessary for suppression of DNA damage response and proper maintenance of 
chromosomal stability (128, 129, 131).  Bunch et al. (2005) determined that reduction of POT1 
first results in telomere lengthening, but after further reduction, triggers loss of telomeric DNA 
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and end-to-end fusions (136).  This suggests that the amount of telomere bound POT1 
determines differential outcomes in vivo. 
 In conclusion, telomeres are specialized DNA-protein complexes that safeguard genomic 
integrity by protecting the ends of linear eukaryotic chromosomes and by replenishing its own 
DNA as a solution to counteract the end-replication problem.  They prevent the 3’ termini from 
being recognized as double-stranded DNA breaks by DNA repair machinery and regulate its 
access to various telomere binding proteins, including those involved in regulating telomerase-
based extension and the ALT pathway.  Its dysfunction leads to degradation by nuclease attack, 
unwanted recombination, telomere damage induced foci (TIF), end-to-end fusions, and  
ultimately leads to cell cycle arrest, senescence, and genome instability (137–140).  These 
processes are intricately involved in cancer and aging. 
 
1.4 Role of Intramolecular DNA G-quadruplex in Telomere Processes 
Telomere maintenance involves regulation between “capped” versus “uncapped” states.  
The “capping” mechanisms used to protect telomere ends involve GQ, POT1, and t-loops, which 
sequester ssTEL to suppress DNA damage signals and prevent degradation, recombination, and 
end-to-end fusion.  On the other hand, telomeres need to be uncapped during DNA metabolic 
processes, such as DNA replication, recombination, repair, telomerase-based extension and 
ALT-dependent elongation, in order to make the ssTEL accessible to involved proteins, 
including telomerase and WRN and BLM helicases.  
An example that illustrates this is a proposed model thought to be involved in regulating 
ssTEL binding by replication protein A (RPA) and POT1 (141).  POT1 is thought to suppress 
activation of the ataxia telangiectasia and Rad3-related (ATR) dependent DNA damage response 
(DDR) by competitively inhibiting RPA binding to ssTEL (142, 143), which, in turn, is known to 
trigger the ATR signaling (144).  However, POT1/TPP1 was found to be inefficient at preventing 
RPA binding to telomeric ssDNA in vitro (141), although Ray et al. (2014) suggests that 
telomeric GQ may enhance this ability (145).  Flynn et al. (2011) discovered that hnRNPA1 
specifically displaces RPA from ssTEL, but not POT1 (141).  This RPA displacing activity is 
inhibited by the telomeric repeat-containing RNA (TERRA) in the early S phase, but then 
restarted in late S phase when TERRA levels decline (146).  Additionally, TERRA was found to 
promote POT1 binding to ssTEL by removing hnRNPA1, which suggested that the 
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reaccumulation of TERRA after S phase helps complete the RPA-to-hnRNPA1-to-POT1 switch 
on ssTEL to transition from the “uncapped” state to the “capped” state after DNA replication 
(141).  This coordination of events is likely to be one of many mechanisms involved in 
RPA/POT1 regulation.  Takai et al. (2011) proposed that binding of POT1/TPP1 to TIN2 also 
better enabled POT1 to compete against RPA by increasing the rate of POT1 binding, which then 
enhances the stability of the POT1/TPP1 complex on ssTEL (147).   
The fact that all three of these ssTEL binding proteins, RPA (148), POT1 (127), and 
hnRNPA1 (149), are able to actively unfold GQ provides strong evidence for its participation in 
telomere maintenance  Additionally, GQ has been found to form preferentially at the very 3’ end 
of telomeric DNA (150).  This is significant because it suggests that GQ is involved in regulating 
processes that depend on accessibility to the 3’ terminus, which includes both telomere length 
maintenance mechanisms: telomerase-based extension and ALT pathway lengthening.  Wang et 
al. (2011) provided evidence for this by systematically studying the size of the 3’ tail required for 
telomeric GQ unwinding, telomerase-based extension, and ALT pathway lengthening, which 
they determined to be 6 nucleotides (nt), 8 nt, and 12 nt, respectively (151).  
Zahler et al. (1991) was the first to show that GQ folding may directly inhibit telomerase 
activity (35).  This suggested that GQ unfolding by hPOT1 may be a mechanism by which it can 
enhance telomerase extension (127, 152, 153).  Zaug et al. (2005) proposed that hPOT1 disrupts 
intramolecular telomeric GQ and traps the ssTEL in an unfolded state to make the 3’ tail 
available for telomerase extension (127).   
However, more lines of evidence have pointed to POT1 having an inhibitory effect on 
telomerase activity both in vitro (154, 155) and in vivo (122, 133, 136).  This suggests that POT1 
can be both a positive and a negative regulator of telomerase extension, and that its effect may be 
conditional on where it is bound.  Lei et al. (2005) explored this possibility and showed that 
when hPOT1 is bound at the end of the ssTEL, it blocks access and inhibits telomerase activity 
(154, 155), but is able to increase the activity and repeat addition processivity of telomerase 
when bound more internally on the ssTEL, where it can leave the 3’ tail accessible (155).   
Additionally, the POT1/TPP1 heterodimer was found to enhance this positive effect and 
significantly increase telomerase processivity (156–160).  Latrick & Cech (2010) suggested that 
POT1/TPP1 increases processivity by slowing primer dissociation when telomerase is actively 
synthesizing DNA and increasing translocation efficiency (158).  In addition, Xin et al. (2007) 
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reported that the POT1/TPP1 heterodimer also enhances POT1 affinity for ssTEL by 5-10 fold 
(157), which is consistent with the role of the POT1/TPP1 heterodimer in protecting ssTEL from 
DNA damage response (DDR) machinery (147).  Further evidence supporting this protective role 
came from Ray et al. (2014), which suggested that telomeric GQ enhances the ability of 
POT1/TPP1 to prevent RPA binding, an ATR-mediated DDR signal (145).   
Hwang et al. (2012) presented a potential mechanism for this by demonstrating that 
POT1/TPP1 displays sliding behavior on ssTEL, which is distinct from the static GQ unfolding 
behavior that they saw in POT1 alone (161).  This difference in behavior suggests that when 
POT1 binds to ssTEL alone, its preference to start from the 3’ tail and its static GQ 
unfolding/binding nature renders the 3’ tail inaccessible to telomerase.  However, when it 
interacts with TPP1, the POT1/TPP1 heterodimer exhibits this distinct sliding behavior and 
dynamic GQ folding and unfolding behavior, to make the 3’ tail accessible and partially resolved 
of GQ.  This behavior may also explain one means by which POT1/TPP1 may enhance 
telomerase processivity (156, 157), although it is not likely to be the only means (160). 
Furthermore, Paeschke et al. (2005) provided evidence for the cell-cycle dependent 
regulation of GQ formation by ciliate telomere end-binding proteins, TEBPα and TEBPβ, which 
are orthologs of POT1 and TPP1, respectively (162).  They found that while TEBPs actively 
stabilize GQ for most of the cell cycle, during the S-phase, TEBPβ is phosphorylated and 
dissociated from the TEBPα-ssTEL complex, and causes GQ to be resolved, making the 3’ 
terminus accessible to telomerase.  This can be explained by the static GQ unfolding to sliding 
model proposed by Hwang et al. (2012), where POT1/TPP1 allows dynamic GQ, but when TPP1 
dissociates, POT1 switches to its GQ unfolding configuration to stably resolve GQ (161).  This 
suggests that the interaction between TPP1 and POT1 can act as a function switch to for POT1’s 
GQ resolving behavior in vivo, and that TPP1 may stimulate telomerase processivity by this 
mechanism.   
In addition to this, studies using small molecule GQ stabilizers revealed that they 
decrease telomerase efficiency (163) while also inhibiting POT1 binding to telomeres and 
inducing its dissociation from ssTEL (164–166).  These findings point to the interplay between 
GQ and POT1 in regulating accessibility to the 3’ tail, and the dependence of their effects on 
distance from the 3’ terminus. 
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Telomeric GQ structures may also been involved in regulating the ALT pathway, which 
requires at least 12 free nucleotides (nt) at the 3’ end of the ssTEL to invade the duplex region of 
telomeric DNA and hybridize with a C-rich strand to initiate template extension (114, 151).  A 
limited tail size and presence of GQ is thought to discourage both invasion and annealing.  GQ 
formation at the very 3’ end may also interfere with T-loop formation, which provides protection 
to the telomere end and is prevalent in ALT cell lines (88).   
Additionally, since ALT is mediated by homologous recombination, proteins that are 
involved in recombination and DNA replication activate this pathway.  Of these proteins, the 
ones that bind to ssTEL from the 3’ end include RecQ family helicases, WRN (44, 167) and 
BLM (59), which are known to have GQ unwinding abilities (118, 130, 168, 169), but require 
ssDNA of sufficient size to load from the 3’ tail (170).  Hwang et al. (2014) confirmed that WRN 
and BLM passively bound to ssTEL in an accessibility dependent manner (171). 
Temime-Smaali et al. (2009) showed that binding of Topoisomerase IIIα (Topo III) to the 
ssTEL is modulated by GQ formation and that its binding is inhibited by telomestatin, a GQ 
binding ligand, in ALT cell lines.  This disruption to the ALT pathway uncaps telomeres (172).  
Thus, while telomeric GQ folding normally plays a protective role by telomere capping, its 
formation during replication of duplex telomeric repeats may adversely affect telomere integrity 
by causing replication fork arrest and DNA breakage within the telomeric tract, which may lead 
to telomere fragmentation and loss if left unresolved (162).   
The diverse conformations and dynamics of intramolecular telomeric GQs (11–26, 34) 
may implicate distinct interactions with various proteins and ligands.  Kinetic studies showed 
that human telomeric GQs, in near-physiological conditions, spend minimal time in an unfolded 
state and has extremely fast folding kinetics (9, 173, 174), with which would affect the nature 
and kinetics of GQ-protein interactions.  Many studies have also reported that antiparallel and 
parallel telomeric GQ structures can coexist and interconvert under near-physiological conditions 
(9, 10, 20, 145, 175).  In telomeric GQ-protein interactions, anti-parallel intramolecular GQ 
structures have been found to be resistant to telomerase extension in vivo (35, 127, 176), while 
parallel intermolecular GQ structures allow telomerase extension (176).  Ray et al. (2014) 
determined that POT1 unfolds the majority of antiparallel GQ, while the parallel conformation 
remains folded (145).   
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G-quadruplex structures may play an important role in regulating accessibility of the 3’ 
end of telomeres to proteins that are involved in a variety of telomeric processes, including 
telomere end protection and telomere length maintenance.  By capping the 3’ tail and making it 
inaccessible, GQ structures inhibit the binding of proteins that need an open 3’ tail to load, such 
as telomerase and the BLM and WRN helicases, which are involved in telomerase-based 
elongation and ALT-based lengthening, respectively.  This gives an advantage to those proteins 
that have some capability to actively disrupt and unfold GQ, such as POT1, which typically play 
an important regulatory role through its dynamic interplay with other telomere-associated 
proteins, including the passive ssTEL binding proteins.   
  
1.5 Oxidative Stress and its Effect on Telomeres and G-quadruplex Structures 
Oxidative DNA damage compromises genome integrity and is the result of reactive 
oxygen species (ROS), which are naturally formed as a byproduct of the mitochondrial 
respiratory chain.  Although ROS play important physiological roles in healthy cells, it gradually 
accumulates and causes gradual accumulation of oxidative DNA damage (177).  In turn, 
oxidative DNA damage is thought to accelerate telomere shortening and cellular senescence, 
which are considered hallmarks of the aging process (178, 179).  DNA bases are particularly 
susceptible to ROS, and resultant base damages may be mutagenic, leading to base mispairing, 
blockage of DNA polymerase during replication, altered affinity for DNA binding proteins, and 
genomic instability, if left unrepaired (180).   
Telomere shortening and oxidative damage, independently as well as cooperatively, 
trigger senescence, apoptosis, and genomic instability, which are key events in cancer and aging.  
Harley et al. (1990) showed that telomere attrition with increasing age is an element in the 
pathobiology of human diseases, particularly aging associated diseases such as cancer and 
premature aging syndromes (90).  Also, oxidative DNA damage on telomeric DNA compromises 
telomere integrity and plays a role in accelerating telomere attrition and cellular aging (179, 181–
183), and in triggering a persistent DNA damage response (184).  Von Zglinicki et al. (1995) 
demonstrated that hyperoxic stress conditions prevent proliferation and cause an increase in the 
rate of telomere shortening from 90 bp per population doubling (PD) to 500 bp per PD (185).  
They also showed that the telomere lengths of these treated cells were as short as those of 
senescent cells, suggesting that telomere shortening leads to proliferative senescence.  Petersen et 
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al. (1998) showed that free radical-mediated accumulation of telomeric single-stranded breaks 
(SSBs), under conditions of hyperoxia, is dependent on applied oxidative stress and significantly 
contributes to an accelerated rate of telomere shortening, which in turn leads to a loss of distal 
telomere fragments and accelerated aging (186).  Conversely, accelerated telomere attrition can 
be countered with anti-oxidative treatments, such as intracellular vitamin C (179, 187).   
Brandl et al. (2011) showed that acute stress conditions cause significantly shortened, 
telomeres, but that attrition happens gradually with time and not immediately after exposure, 
suggesting that oxidative damage may be retained in telomeres (188).  Harbo et al. (2012) then 
showed that acute oxidative stress results in an increased number of ultra-short telomeres, even 
in telomerase positive cells, and that the number of ultra-short telomeres correlates strongly with 
the percentage of senescent cells, while the mean telomere length does not (181).  This suggests 
that damage inducing ultra-short telomeres lead to senescence, rather than gradual attrition.   
Telomeric DNA is particularly susceptible to single-stranded breaks (SSBs) and base 
damage by oxidation, due to its G-rich nature and inability to repair as efficiently as elsewhere in 
the chromosome (186, 189).  The efficacy of repair on telomeres is affected by structure, with 
fork-openings, D-loops, and 3’ overhang repairing less effectively, and by telomere-associated 
proteins, such as POT1, which have been shown to hinder access of repair proteins to telomeres 
and lead to accumulation of abasic sites and SSBs (180, 189, 190).  These may contribute to 
accelerated telomere shortening, which in turn triggers a persistent DNA damage response 
(DDR) during replicative senescence (138, 140, 184).  Up to half of the DNA damage foci and 
all persistent foci are found at telomeres, regardless of telomerase activity, suggesting that 
telomeres are favored targets of DDR and are important to the aging process (184).   
While hTERT can inhibit replicative senescence it cannot rescue premature senescence 
induced by DNA damage (191).  Despite the ability of telomerase to elongate telomeres, under 
oxidative stress, cells eventually show a G1/S proliferative arrest similar to senescence.  For 
example, in fetal lung fibroblasts, hTERT-mediated immortalization only occurs under hypoxic 
conditions (192), suggesting that oxidative stress inhibits the ability of telomeres to form 
functional capped structures despite adequate telomere length.  Hewitt et al. (2012) also showed 
that an age-dependent increase in frequencies of telomere-associated foci occur regardless of 
telomere length (184).   
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On the other hand, Vallabhaneni et al. (2013) found that telomerase deficiency 
exacerbates telomere shortening in Nth1 deficient mouse cells and base excision repair 
cooperates with telomerase to maintain telomere integrity (182).  This suggests that oxidative 
DNA damage may be the element preventing telomerase activity and processivity, and that other 
regulatory mechanisms are at play.  Findings by Kovalenko et al. (2010) provide evidence for 
this by showing that TERT contains mitochondria targeting signals and can respond to oxidative 
stress by localizing to mitochondria, where they can regulate apoptotic responses to oxidative 
stress (193).   
Oxidative DNA damage is mainly repaired by the base excision repair (BER) pathway, 
which is initiated by a DNA glycosylase that recognizes and excises specific base damage, and 
also involves coordinating recruitment of endonucleases, polymerases, and ligase proteins (194, 
195).  Mammalian cells express five DNA glycosylases with overlapping but distinct specificity 
for various oxidative DNA base lesions: Ogg1, Nth1, Neil1, Neil2, and Neil3 (194, 196).   8-
oxoguanine DNA glycosylase 1 (Ogg1) mostly recognizes oxidized guanine lesions from duplex 
DNA, while endonuclease III-like protein 1 (Nth1) primarily recognizes oxidized pyrimidines 
from duplex DNA (194).  Zhou et al. (2013) determined that Neil3 and Neil1 DNA glycosylases 
can remove oxidized bases from ssTEL and GQ structures, and that Neil3 exhibits a strong 
preference for Tg in telomeric sequences and is the only one that has excision activity on Tg in 
GQ (196).  In addition, they showed that none of the glycosylases has activity on GQ DNA 
containing 8OG.  Rhee et al. (2011) also demonstrated that hOgg1 cannot efficiently excise 8OG 
near a 3’ overhang opening (189).  
Guanine has the lowest oxidation potential among nucleic acid bases and consecutive 
runs of guanine within a sequence (ie. telomeres) further lower the oxidation potential (197).  Its 
major oxidative product, 8-oxo-7,8-dihydroguanine (8OG), is one of the most common oxidative 
DNA lesions, and accumulates in telomeres during oxidative stress (198).  Oikawa et al. (2001) 
found that guanine residues in telomeres are about five times more sensitive to oxidative stress 
and UV irradiation, with a higher rate of 8OG accumulation and telomere shortening, than in 
nontelomeric sequences (197).  Wang et al. (2010) demonstrated that Ogg1 deficiency results in 
the accumulation of oxidative 8OG lesions in telomeres and disrupts telomere integrity (199).  
Additionally, Opresko et al. (2005) showed that 8OG in telomere inhibits telomerase activity and 
significantly reduces the binding affinity of TRF1 and TRF2 proteins to the duplex telomere 
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sequence, leading to disruption of telomere length, maintenance and function (200).  Binding 
was disrupted when intermediates of base excision repair, such as abasic sites or single 
nucleotide gaps, were presented within the telomeric tract, as well.  This is significant as TRF2 is 
directly involved in regulating telomere length and protecting telomeres, which includes doing so 
by binding with DNA repair proteins (200).  On the other hand, telomeric D-loops containing 
8OG have also been shown to be preferred substrates for WRN and BLM helicases and POT1 
(201).  Although 8OG does not block replication by DNA polymerase, if 8OG is left unrepaired, 
it becomes highly mutagenic and could alter telomeric sequence (202).  This alteration can 
happen by 8OG pairing with adenine, and leading to GC to TA transversions after two rounds of 
replication (202).  These finding indicate that 8OG compromises telomere integrity and plays a 
role in telomere shortening and cellular aging.       
Studies have also shown that 8OG is more reactive and more prone to form in quadruplex 
than duplex DNA, both in telomeric DNA and non-telomeric regions (203–205).  Salt conditions 
and position of 8OG substitution are known to affect formation and structural dynamics of 
intramolecular telomeric GQ (198, 203).  Studies have shown that when 8OG is incorporated in 
the end of telomeric guanine triplet, GQ formation is observed, but when it is incorporated in the 
middle of the triplet, the GQ is further destabilized and  multiple structures are produced (198, 
203).  Szalai et al. (2002) also showed that 8OG incorporation at 5’ position of the triplet inhibits 
telomerase activity, while one in the middle triplet does not (203).  However, it is not clear 
whether the modulation in telomerase activity is due to the disruption of GQ or the oxidation of 
G to 8OG.  Other types of lesions or mutations have been reported to show similar patterns of 
destabilization depending on position, even though extent of destabilization is dependent on 
lesion type (206–209).  Therefore, further studies are needed to explore the effect of oxidative 
stress on telomeric GQ structure and its impact on telomere regulation. 
  
1.6 Single-Molecule Förster Resonance Energy Transfer (smFRET)  
Single-molecule Förster Resonance Energy Transfer (smFRET) is a powerful 
spectroscopic technique that measures the efficiency of non-radiative energy transfer between an 
excited fluorescent donor molecule and an acceptor molecule.  The energy transfer occurs by 
dipole-dipole interaction, and the energy transfer efficiency is dependent on the distance between 
the donor and acceptor fluorophores, the spectral overlap between donor emission and acceptor 
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absorption, and the relative orientation of the donor emission and acceptor absorption dipole 
moments (210).  Greater spectral overlap between donor emission and acceptor absorption 
maximizes energy transfer, while spectral separation between donor and acceptor emissions 
minimize donor leakage. 
Since it is predominantly dependent on dye-to-dye distance, FRET can be used as a 
molecular ruler with greatest sensitivity in the 30-80 Å range.  However, it also needs to be 
corrected for differences in quantum yield and detection efficiency between the donor and 
acceptor.  The gamma correction factor (γ) is a ratio of change in acceptor intensity to change in 
donor intensity upon acceptor photobleaching.  As an equation, the FRET efficiency, E, is equal 
to IA/(IA+γID), where IA is the acceptor intensity, ID is the donor intensity and γ is the gamma 
correction factor (211).  Since FRET efficiency is a ratiometric measure, it is independent of the 
power of the excitation laser.   
An imaging modality used for smFRET is total internal reflection fluorescence (TIRF) 
microscopy, which allows simultaneous observation of multiple DNA-protein interactions with 
high spatial and temporal resolution readings per pixel.  It uses a wide-field microscope and can 
be set up in two ways: objective-type (oil immersion) or prism-type (water immersion).  In 
prism-type TIRF microscopy (Figure 1), an inverted microscope is used and the excitation beam 
is focused through a lens and directed through a prism to hit the sample at a shallow incident 
angle for total internal reflectance (TIR) (212).  TIR at the interface between the quartz slide and 
aqueous imaging buffer creates an evanescent field of illumination, which is used to excite the 
fluorophores of the surface-immobilized sample at a 100 to 200 nm penetration depth (212).  The 
energy emission of both the donor and acceptor dyes is collected by a water-immersion 
objective, sent through a long pass filter to remove scattered light, and split into donor and 
acceptor emission before being sent to a highly sensitive detector. 
FRET overcomes the limitations of ensemble measurements, which require population 
averaging and cannot resolve subpopulations and their non-synchronous dynamics (210).  Since 
FRET can be used as a molecular ruler, changes in FRET can be used to detect structural 
changes within biological molecules (e.g., GQ folding) or relative motion between two 
interacting molecules (e.g., DNA-protein interactions), in real-time.  For example, GQ formation 
and unfolding can be monitored via changes in FRET efficiencies (Figure 2).  Previous smFRET 
experiments have been able to reveal the distribution of behaviors in human telomere GQ folding 
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conformations and dynamics and show interconversion between two different GQ conformations 
involves an obligatory transient intermediate (10, 175).   
 
1.7 Study Objective  
The guanine-rich nature of human telomeric DNA allows it to adopt a G-quadruplex 
(GQ) secondary structure and also renders it particularly susceptible to the most common 
oxidative DNA lesion, 8-oxo-guanine.  GQ structures at the 3’ single-stranded G-overhang are 
involved in regulating telomere processes that depend on accessibility of the 3’ end, such as 
telomere length maintenance.  Likewise, oxidative stress is known to play an important role in 
telomere length dysregulation and appears to be a major trigger of senescence, apoptosis, and 
genomic instability, which are key events in cancer and aging.  Despite the multitude of studies 
that relate oxidative stress to telomere regulation, few have studied the effect of oxidative DNA 
damage on the structural dynamics of the G-overhang and on telomeric DNA-protein 
interactions.  To my knowledge, no study has yet investigated the effect of oxidative DNA 
damage on single-stranded telomeric GQ in the context of its regulatory role at the 3’ terminus.  
Understanding how oxidative DNA damage affects GQ dynamics will be instrumental for further 
elucidating the effect of oxidative stress on the interaction between telomeric DNA and 
telomere-associated proteins.  Here, we examine the effect of 8-oxo-guanine on the structural 
dynamics of telomeric GQ and investigate the implications it may have for the accessibility of 
the 3’ telomere end.   
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Study Design 
We used single molecule FRET to characterize the effect of 8-oxoguanine damage on: 1) 
the structural dynamics of single-stranded telomeric GQ, 2) accessibility of GQ to passive 
binding, as modeled by complementary DNA probes, and 3) accessibility of GQ to active 
binding, as modeled by POT1 binding.      
DNA constructs of two different lengths of single-stranded tail were examined: 
(TTAGGG)4 with 4 hexameric repeats (G4), which can only form one GQ structure, and 
(TTAGGG)8 with 8 hexameric repeats (G8), which has the capability of forming up to two GQ 
structures.  For the oxidative damaged constructs, the 8-oxo-guanine modified base was placed 
in the 3’ most middle G tetrad (8OG-G4, 8OG-G8), where the 8-oxo-G is the most disruptive in 
GQ folding (198, 203, 206).  A mutant control construct with a ”C” substitution at the same 
position was also studied for comparison (G4mut, G8mut).  For each construct length, we 
studied the structural dynamics of the unmodified GQ construct (G4, G8), the 8-oxo-guanine 
construct (8OG-G4, 8OG-G8), and mutant control construct (G4mut, G8mut).   
We studied the passive binding of complementary telomeric probes to model proteins that 
cannot actively unfold GQ without a 3’ tail accessible for loading.  These proteins include 
telomerase and WRN and BLM helicases, which are the key processing enzymes for telomere 
length maintenance.  Hwang et al. (2014) showed that the binding behavior of these proteins was 
similar to that of the 12 nucleotide (nt) complementary probe (C2); tightly folded GQ DNAs 
including G4 and G8 yielded the lowest accessibility, whereas G6 and G7 allowed the highest 
accessibility, likely due to the free single stranded portion of DNA uninvolved in the GQ 
structure (171).  The use of this probe length is in agreement with findings from Wang et al. 
(2011), which investigated the 3’ tail size dependence of telomere extension by telomerase (8 nt 
minimum), alternative lengthening of telomere (ALT) mechanism (12 nt minimum), and 
telomere GQ unwinding by helicase (6nt minimum) (151).   
For this, we used unlabeled DNA probes with, two (C2) to four (C4) CCCTAA repeats.  
The longer probe was used to determine if there are any differences in binding efficiency that 
arise from partial accessibility to DNA substrate or stability of probe binding.   
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We observed the binding behavior of POT1 as the model for proteins that actively unfold 
GQ, which include RPA and various hnRNPs.   
 
2.2 DNA Substrates and Preparation 
 Oligonucleotides, listed in Table 1, were purchased from Integrated DNA Technologies 
(Coralville, IA) and Midland Certified Reagent (Midland, TX).  Unlabeled DNA with a 3’ 
amino-C7 modifier were 3’ end-labeled with monofunctional NHS-ester conjugated Cy3 (GE 
Lifesciences) using ethanol precipitation.  Briefly, 10 mM of Cy3 dye was incubated with 0.15 
mM of amino modified DNA in 85mM sodium tetraborate buffer (pH 8.5) overnight at room 
temperature in the dark.  The labeled oligonucleotides were purified by ethanol precipitation.  
Partial duplex DNA (pdDNA) constructs with an 18 bp long duplex stem and a single-
stranded telomeric tail, were used for all experiments, and were prepared by annealing 3’-Cy3 
labeled telomere single-stranded DNA (ssDNA) with biotinylated 5’-Cy5 labeled 18mer ssDNA 
at a molar ratio of 1.5:1 in 10mM Tris-HCl pH 8, 100mM KCl.   
 
2.3 Reaction Conditions 
 Single molecule FRET experiments were conducted in 20mM Tris-Cl pH 7.5, 100mM 
KCl.  The imaging buffer were supplemented with an oxygen scavenging system (0.8 mg/ml 
glucose oxidase, 0.8% glucose, 3 mM 6- hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic 
(Trolox), and 0.03 mg/ml catalase).  All buffer materials were purchased from Sigma-Aldrich 
(St. Louis, MO).  All measurements were performed at room temperature (23±1°C).   
 
2.4 Single Molecule FRET Measurements  
Single molecule FRET experiments were carried out in flow chambers assembled from 
PEG passivated quartz slides and coverslips.  The quartz slides and coverslips were cleaned by 
sonication in 2.5% Alconox, acetone, methanol, 1M potassium hydroxide, and torching.  They 
were then coated with a mixture of 97% mPEG-silane (methoxy-PEG5000-silane) and 3% 
biotin-PEG5000-silane, which were both purchased from Laysan Bio, Inc. (Arab, AL). 
 A homemade wide-field prism-type total internal reflection fluorescence (TIRF) 
microscope was used to take measurements.  Cy3 donor dyes were excited using a solid-state 
532 nm laser.  Cy3 and Cy5 emission signals were collected through a water-immersion 
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objective (Olympus Uplan S-Apo; 100x, NA=1.4) and detected using an electron multiplying 
charge-coupled device camera (iXon DU-897ECS; Andor Technology).  Data were recorded at a 
time resolution of 100 ms and the imaging frames were processed using custom scripts written in 
IDL to detect molecules and generate fluorescence intensity time trajectories for each molecule 
(211). 
Biotinylated pdDNA constructs were immobilized to PEG passivated surfaces via biotin-
neutravidin interaction, and solutions with substrates, probes, and proteins were flown through 
chambers using a syringe pump at a rate of 10 μl/sec.  For each assay condition, 30 short movies 
were taken before flowing in the oligo probes or POT1 protein, and again 15 minutes after, to 
generate smFRET histograms.  A series of long movies were taken before and after flow as well 
to generate FRET traces.  One long movie was taken at the time of flowing in the oligo probes or 
POT1 protein, to capture flow kinetics.  10 nM of C2-C4 oligo were used for passive probe 
binding experiments, and 400 nM of POT1 was used for active POT1 binding experiments.  
Recombinant human POT1 proteins were generously provided by Patricia Opresko (University 
of Pittsburgh) and purified by Noah Buncher from her lab, using a baculovirus/insect cell 
expression system described previously (213). 
 
2.5 Data Analysis 
Single molecule traces were viewed and analyzed using MATLAB.  FRET efficiency, E, 
was calculated as a ratio between the acceptor intensity and the total donor and acceptor 
intensity.  The values were corrected for background and donor leakage into the acceptor 
channel.  The initial 10 frames of over 7000 smFRET traces were binned into FRET histograms.  
A threshold was applied based on fluorescence intensities and histograms were normalized. 
The peak-to-peak times between dynamic state transitions and the time from flow of 
probes and POT1 to time of binding (δt), were collected from individual smFRET traces using 
MATLAB.  The individual dwell times for over 200 molecules were binned into dwell-time 
histograms and fitted to a single exponential decay to calculate the half-life using Origin 9.0 
(OriginLab Corporation, Northampton, MA).  Binning sizes varied based on the type and range 
of data collected.  Means and standard errors were calculated for all parameters.     
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CHAPTER 3: RESULTS AND DISCUSSION 
 
3.1 DNA Structural Dynamics 
 We studied the conformation and structural dynamics of G4 and G8 constructs with and 
without 8-oxo-guanine modification.  The two FRET pair dyes, Cy3 and Cy5, were positioned at 
either end of the GQ forming DNA and exhibited high FRET when GQ folding occured. The 
FRET histogram was built from FRET values collected from over seven thousand DNA 
molecules imaged on a surface, while the single molecule traces came from a single DNA 
molecule.  The G4 DNA construct displays a steady high FRET state (0.9), indicative of a stable 
GQ conformation (Figure 3a-c; top).  In contrast, both mutant substrates exhibited a distinct and 
decreased FRET state, revealing a flexible secondary structure.  The slightly lower FRET state of 
8OG-G4 (Figure 3a-c; bottom) compared to G4mut (Figure 3a-c; middle), suggests that 8OG 
causes a greater disruption in GQ secondary structure than a base pair substitution.  Additionally, 
G4mut showed occasional transient FRET fluctuations (<2 sec) from 0.75 to 0.84-0.9, while 
8OG-G4 showed frequent and highly dynamic transitions from 0.66 to 0.84-0.9.  The dynamics 
to high FRET state suggests that the substrates can still achieve a tight GQ conformation and is 
inclined to this GQ state despite destabilization.  The rate at which these transient events occur 
(δt) was analyzed for both mutant constructs (Figure 3d).  8OG-G4 was found to have a faster 
rate of dynamics than G4mut, with a half-life of 3.8 seconds and 17.7 seconds, respectively.  
Together, these findings provide evidence for greater destabilization in the 8OG model than in 
the base substitution substrate, although both mutants are destabilized relative to the control 
construct with tight GQ conformation.    
 For G8 length constructs, G8 (Figure 4; left) shows a great variety of static and dynamic 
smtraces with transient dips at various FRET states, and the diversity of populations is evident in 
its smFRET histogram.  G8mut (Figure 4; middle) shows occasional transitions from 
predominantly 0.48 and 0.59, with the major population at 0.48 and minor population at 0.59.  
8OG-G8 (Figure 4; right) reveals an unresolved FRET histogram indicative of a flexible 
secondary structure, with a peak at 0.49.  Single molecule traces also show that 8OG-G8 is 
predominantly in the loosely folded (one GQ) state with frequent and fast transitions to a tightly 
folded two GQ state.  8OG-G8 appears to show faster dynamics compared to G8mut as 
evidenced by a lower percentage of static and stepping traces and significantly higher transiently 
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dynamic traces.  The greater diversity of dynamic behavior seen in G8 and the consistent pattern 
of transient dynamics seen in G8mut and 8OG-G8 suggest that G8mut and 8OG-G8 constructs 
may be “closed” by the mutation at the end G-triplet, which restricts their dynamic behavior.  
Patterns in conformational dynamics between G8mut and 8OG-G8 parallels those seen in the G4 
length constructs.   
 
3.2 Probe Accessibility 
 We determined the accessibility of telomeric ssDNA constructs by passive binding to 
complementary probes of different lengths.  As anticipated, G4 (Figure 5b) was inaccessible by 
any probe length.  G4mut (Figure 5c) and 8OG-G4 (Figure 5d) shifted its FRET states readily for 
all probe lengths, suggesting that they are fully accessible for all probes.  Since up to two probes 
may bind to G4 length constructs, we were able to see two distinct bound FRET states, 0.55 (1 
probe) and 0.3 (2 probes) for G4mut substrates.  However, we only saw one FRET state 
indicating 2 probe binding for 8OG-G4, suggesting that 8OG-G4 is more readily accessible than 
G4mut.   
 For G8 length constructs, G8 (Figure 6; left) showed minimal change after addition of C2 
and C4 length probes, with partial accessibility for the C3 probe.  Interestingly, the partial 
accessibility seen in G8 seems to occur in the low FRET G8 conformations, which is thought to 
be representative of one GQ structure and a relaxed conformation in the accessible region, as 
opposed to tight conformation with two GQ structures as indicated by the high FRET population.  
G8mut (Figure 6; middle) and 8OG-G8 (Figure 6; right) showed FRET shifts after addition of all 
probes, indicating accessibility.  Furthermore, greater FRET shifts were seen with binding by 
longer probes.  In all, the pattern of accessibility for the G8 length constructs paralleled those of 
the G4 length constructs.   
 The % accessibility for each construct and probe condition was calculated by subtracting 
normalized histograms taken before and after probe binding and dividing that by the normalized 
histogram before probe binding (Figure 7).  Histogram subtraction suggests that mutant 
constructs have greater (or quicker) accessibility than control constructs.  G4 is not accessible by 
any of the probe lengths, while G8 is minimally accessible, with partial accessibility using the 
C3 probe.  G4mut and 8OG-G4 are fully accessible for all probes, while G8mut and 8OG-G8 are 
mostly accessible, but with less accessible for the C2 probe.  G8mut and 8OG-G8 showed 
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greater accessibility for C3 and C4, with slightly greater accessibility using C3.  These 
preliminary results suggest G8mut has slightly greater % accessibility than 8OG-G8, but further 
study is needed due to the complexity of G8 behavior.   
 For our kinetic analysis on G4 length constructs, we measured the time to probe binding 
(δt) (Figure 8).  8OG-G4 was found to have faster binding kinetics than G4mut for all probe 
lengths.  Of note, binding of the C4 probe was very slow for the G4mut construct, suggesting 
G4mut may have a secondary structure with stronger intramolecular bonds that make binding of 
a probe with the same length as the construct, more difficult.  However, C3 probe exhibited the 
fastest binding for G4mut, with 78% binding, compared to 65% binding for C2 and 50% binding 
for C4, seen within first two minutes (data not shown).  The slower time seen by C2 probe 
binding may be due to the extra time needed for second probe binding.  Additionally, a 
significant minority group of traces exhibited two step binding for all probes, indicating an 
intermediate step in one probe binding.  Interestingly, it was relatively rare in C2 probe binding 
and more often seen in C3 and C4 probe binding.  The intermediate steps were observed less in 
the 8OG-G4 substrate.  Binding kinetics may be affected, in part, by the intrinsic differences in 
dynamic patterns between the two mutant constructs before probe binding.  As discussed earlier, 
G4mut displays slower dynamics to tight GQ conformation state than 8OG-G4. 
In smtraces, G8 appeared to have more traces that show binding, but it is difficult to 
resolve because the inherent G8 behavior shows transitions from higher to lower FRET states 
that cannot be distinguished from probe binding.  G8mut showed faster and more effective 
binding for C3 probes than C4 probes and C2 probes.  Additionally, G8 length constructs 
appeared to bind slower than G4 length constructs, which is as expected due to how many probes 
can bind.  8OG-G8 appeared to bind faster than G8mut for all constructs.  Further analysis was 
complicated by the complex and highly variable nature of G8 length constructs.  Probe binding 
was difficult to resolve from intrinsic DNA behavior and bound, unbound, and 
photobleaching/donor only events had overlapping thresholds.  Despite these complications, our 
observations suggest the behavior of G8 length constructs parallel behavior of corresponding G4 
length constructs.  Also of note, dissociation of probe after binding was not seen. 
 
3.3 POT1 Binding 
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The G4 control construct does not exhibit immediate binding like G4 length mutant 
constructs.  As expected, G4 showed only partial GQ unfolding in K+ conditions due to 
existence of both antiparallel and parallel GQ conformations (145).  Trace analysis for G4 
revealed that of the molecule bound, 88% of traces display a stable binding process, mostly from 
one-step binding from 0.88 to 0.45, while the other 12% display a dynamic binding process, 
suggestive of POT1 struggling to disrupt GQ before stably binding.  Later traces indicated than 
POT1 remains stably bound.  In G4mut, binding happened immediately, with 33% exhibiting 
dynamic binding processes that extended before stable binding.  About 8.5% continued dynamic 
fluctuations.  In 8OG-G4, there were very few dynamic binding processes and most traces 
showed immediate binding.  However, ~12% displayed more erratic dynamics indicative of 
dynamic interactions or unstable binding with similar dynamic fluctuations in later traces.   
 For the G8 control construct, ~30% of molecules showed dynamics before and after 
POT1 binding.  35% stable binding was seen within two minutes and 10-15% occurred later.  
22% of traces showed dynamic binding.  In G8mut, ~81% bound with about half showing 
dynamic or unstable binding and 38% showing dynamic binding later.  For 8OG-G8, 78% bound 
with ~39% displaying dynamic or unstable binding within the first two minutes and 24% 
displaying dynamics later, suggesting that they somewhat appear to stabilize.  Dissociation of 
POT1 was rarely seen.  Thus, study of traces showed that a population of base substitution 
mutants has binding processes, while 8OG mutants show unstable binding. 
 Calculations of accessibility to POT1 using histogram subtraction for both G4 length 
constructs and G8 length constructs indicate that base substitution has greater accessibility than 
8OG, which in turn has greater accessibility than control construct.  For the G4 length constructs 
(Figure 9), G4mut was found to be 97.5% accessible, while 8OG-G4 was found to be 85.5% and 
G4 was 52.3%.  For the G8 length constructs (Figure 9), G8mut was found to be 84.3% 
accessible, while 8OG-G8 was 68.8% and G8 was 65.9%.  Additionally, study of POT1 binding 
time, showed that 8OG-G4 bound faster than G4mut, and both were much faster than G4 (Figure 
10).  The average binding time for G4mut was found to be 7.82 seconds and that of 8OG-G4 was 
found to be 4.75 seconds.  This is similar to an exponential fitting used to determine a half-life of 
7.4 seconds for G4mut and a half-life of 4.2 seconds for 8OG-G4.  Fitting to a cumulative 
distribution curve (Figure 11) showed that 8OG-G4 binds faster but then plateaus at a lower % of 
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bound molecules than G4mut.  This is similar to estimates taken by frequency count of smtraces 
and % accessibility calculated.   
 Histogram subtraction and frequency counts in smtraces both seem to suggest a slightly 
lower accessibility for 8OG construct compared to the single base substitution.  This may be due 
to the intrinsically faster dynamics seen.  However, this result may be affected by an artifact of 
the differences in FRET values of the DNA constructs and the broader peaks for the 8OG 
constructs.  Another factor to be taken into consideration is the population of high FRET traces 
that do not readily bind.  Since the percentage of this population is variable between runs and is 
thought to be influenced by experimental conditions, the weight of this population may serve as 
an artifact that skews these results as well.  Further study is needed to fully address the 
differences in accessibility between mutant constructs. 
 
3.4 Future Directions 
Small molecule GQ binding ligands can be used to regulate telomere maintenance by 
locking telomeric DNA in a GQ conformation.  This GQ stabilization is thought to inhibit 
telomerase activity and POT1 binding (35, 151, 163, 166, 214–218), prevent GQ unwinding, 
which is required for the ALT pathway (151, 219), and cause rapid dissociation of telomere 
capping proteins, TRF1 and POT1 (166), which leads to degradation of the ssTEL and an 
increase in DNA damage signals at the telomeres (54, 164, 165, 220), and ultimately to apoptosis 
(165, 221).   
The involvement of GQ structures in telomere maintenance makes it an attractive target 
for cancer therapeutics.  However, since GQs are involved in all of these telomeric processes, 
great care needs to be taken to understand the differential effects of various designs of GQ 
binding ligands.  A study by de Cian et al. (2007) dissected the effect of GQ ligands on 
telomerase inhibition, and found that although most GQ ligands can inhibit the initiation of 
telomerase extension, only few molecules can interfere with telomerase processivity (222).  This 
highlights the importance of further studying the mechanism of action of GQ binding ligands, 
which involves developing a better understanding GQ conformations and dynamics in order to 
improve drug affinity, specificity, and selectivity for cancer cells over normal cells.  For 
example, for targeting ssTEL, drug design may seek excellent selectivity for single stranded 
DNA over double stranded DNA (164–166) among other parameters.   
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The results from our study may have implications for the design of GQ binding ligands.  
Most standard chemo- and radiation- therapies are based on reactive oxygen species (ROS) 
induction.  Therefore, if GQ binding ligands are to be used as an adjuvant therapy, oxidative 
stress needs to be taken into consideration during drug design.  This requires further studies on 
the effect of oxidative damage at ssTEL, in the context of its impact on GQ ligand binding 
affinity due to differences in GQ conformation and dynamics, as well as its effect on protein 
binding and activity.   
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CHAPTER 4: CONCLUSION 
 
We used single-molecule FRET to characterize the effect of oxidative stress on the 
structural dynamics and accessibility of single-stranded human telomeric DNA (ssTEL).  Stable 
and tight G-quadruplex (GQ) folding observed in K+ salt conditions was disrupted by a single 8-
oxoguanine (8OG) mutation and generated rapid dynamics from looser secondary conformation 
to a tighter GQ folded state. Although both mutations affected Hoogsteen basepairing and G-
quadruplex (GQ) stability, 8-oxoguanine (8OG) affected GQ stability more than a single 
complementary base substitution.  Kinetic analysis also showed a higher frequency of dynamics 
and faster dynamics with 8OG damage than with a single base substitution.   
We also determined that the destabilization of GQ secondary structure allows 
complementary probe binding, which is representative of passive binding of proteins such as 
WRN and BLM helicases, and telomerase.  Kinetic analysis showed faster probe binding in 8OG 
mutation than single base substitution. Although both mutants showed a great increase in 
accessibility, 8OG showed slightly lower accessibility, perhaps due to the intrinsically faster 
dynamics seen.  Thus, structural dynamics induced by the 8OG lesion contributes to increased 
binding of complementary DNA probes, suggesting enhanced accessibility of 3’ ssTEL to 
passively interacting molecules. 
Our findings regarding active GQ unfolding by POT1 showed partial GQ unfolding for 
stable G4 in K+ conditions, as expected due to existence of both antiparallel and parallel GQ 
conformations.  In contrast, both mutants were highly accessible, although our results suggest the 
single base substitution allows greater accessibility than 8OG damage, while 8OG exhibited 
faster binding kinetics. 
Although distinct in nature in accessibility and kinetics, both single base oxidative 
damage and single base mutation compromise GQ structure and this destabilization leads to 
enhanced accessibility of the 3’ ssTEL tail.  This has implications for passively binding proteins 
that require a 3’ tail to load and for actively GQ unfolding proteins.  Our findings provide 
evidence supporting the significance of the GQ secondary structure in telomere regulation, 
particularly for telomere length maintenance. 
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FIGURES AND TABLES 
 
 
Figure 1.  Prism-based total internal reflection fluorescent (TIRF) microscope setup. This 
imaging modality allows simultaneous observation of multiple single molecule events and 
interactions for smFRET by high spatial and temporal resolution readings.  
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Figure 2.  DNA constructs immobilized on PEG-passivated surface via biotin-neutravidin 
interaction. (A) Construct in a low FRET state suggests an unfolded state, while (B) construct in 
a high FRET state suggests a folded GQ state.  
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Construct Sequence 
G4 5’ - TGG CGA CGG CAG CGA GGC TTA GGG TTA GGG TTA GGG TTA GGG /3Cy3/ 
G8 5’ - TGG CGA CGG CAG CGA GGC (TTA GGG)8 /3Cy3/ 
G4mut 5’ - TGG CGA CGG CAG CGA GGC TTA GGG TTA GGG TTA GGG TTA GCG /3Cy3/ 
G8mut 5’ - TGG CGA CGG CAG CGA GGC (TTA GGG)7 TTA GCG /3Cy3/ 
8-oxo-G4 5’ - TGG CGA CGG CAG CGA GGC TTA GGG TTA GGG TTA GGG TTA G(8oxodG)G /3Cy3/ 
8-oxo-G8 5’ - TGG CGA CGG CAG CGA GGC (TTA GGG)7 TTA G(8oxodG)G /3Cy3/ 
  
18mer 
bottom 
5’ - /Cy5/ GCC TCG CTG CCG TCG CCA – 3’ biotin (annealed to all Cy3 sequences) 
  
Probe Sequence  
C2 5’ - CCC TAA CCC TAA 
C3 5’ - CCC TAA CCC TAA CCC TAA 
C4 5’ - CCC TAA CCC TAA CCC TAA CCC TAA 
 
Table 1. DNA Constructs and Probes. The table lists the sequences for the telomeric DNA 
constructs used at the top, followed by the sequence for the biotinylated 18mer construct 
annealed to the telomeric DNA constructs.  At the bottom are the sequences of the probes used in 
the passive binding accessibility assay.       
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Figure 3.  Effect of 8OG on conformation and dynamics of G4 length telomeric overhang.  
(A) DNA schematics of the three types of constructs: control (G4), complementary single base 
substitution (G4mut/G4m), and 8-oxo-guanine mutant (8OG-G4/G4o).  (B) Single-molecule 
frequency histograms of DNA show shift in FRET state, indicative of looser secondary structure.  
(C) Single molecule traces also suggest destabilization as indicated by the transient dynamics to 
the high FRET “tight” state.  (D) Dwell time distribution on mutant constructs confirmed that 
G4mut has slower rate of dynamics than 8OG-G4, and is fitted with an exponential decay 
function.  The control construct (G4) predominantly remains stable at a very high FRET state 
(0.9), which suggests a tight GQ conformation.   
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Figure 4. Effect of 8OG on conformation and dynamics of G8 length telomeric overhang.  
Normalized histogram and representative single molecule trace for G8 (left), G8mut (middle), 
and 8OG-G8 (right).  G8 shows multiple populations of FRET values and the greatest diversity 
of traces with no predominant pattern.  G8mut shows two distinct populations, well fitted with 
two Gaussian fits, and less frequent and slower dynamics than 8OG-G8, which is less resolved, 
but typically shows fast dynamics between tightly folded (two GQs) and loosely folded (one GQ) 
states.  This agrees with our observations in the G4 length constructs.    
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Figure 5.  Accessibility of G4 length constructs by C2, C3, and C4.  (A) Schematic of how 
complementary probes may bind to the G4 length constructs.  Histograms show before (top row) 
and after probe binding to illustrate FRET shifts.  The blue area indicates the FRET state of 
construct before probe binding for the G4 (B), G4mut (C), and 8OG-G4 (D) constructs.  As can 
be seen, G4 shows no change and is not accessible by any probe length (C2, C3, C4), while both 
G4mut and 8OG-G4 shift FRET states readily for all probe lengths.  Note that up to two C2 
probes may bind to the G4 length constructs, which can be seen in the case of the G4mut 
construct, which shows two distinct bound FRET states (0.55 and 0.3), indicating one or two 
probe binding, respectively.  
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Figure 6. Accessibility of G8 length constructs by C2, C3, and C4.  Normalized histogram of 
G8 (left) construct before (top) and after probe binding shows that G8 has minimal accessibility 
for the C2 and C4 probe, but partial accessibility with the C3 probe.  Meanwhile, G8mut 
(middle) and 8OG-G8 (right) show greater accessibility: high accessibility for C3 and C4, and 
partial accessibility for C2.  The blue area indicates the FRET state of construct before probe 
binding. 
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Figure 7. C2-C4 Accessibility by DNA construct.  The % accessibility for each construct and 
probe condition was calculated by subtracting normalized histograms taken before and after 
probe binding using the formula provided.  
 
 
 
 
 
 
 
 
 
 
 
% 𝑎𝑐𝑐𝑒𝑠𝑠𝑖𝑏𝑖𝑙𝑖𝑡𝑦𝐷𝑁𝐴 =
|∑ 𝐹𝑅𝐸𝑇(𝐷𝑁𝐴+𝐶2) − 𝐹𝑅𝐸𝑇𝐷𝑁𝐴∆ <0 |
∑ 𝐹𝑅𝐸𝑇𝐷𝑁𝐴∆ <0
× 100%, 
  𝑤ℎ𝑒𝑟𝑒 ∆ = 𝐹𝑅𝐸𝑇(𝐷𝑁𝐴+𝐶2) − 𝐹𝑅𝐸𝑇𝐷𝑁𝐴 
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Figure 8. Kinetics of probe binding for G4 length mutant constructs.  (A) Single molecule 
traces were used to measure the time to probe binding (δt).  (B) Average binding time was 
plotted with error bar indicating standard error.  (C) Cumulative distribution curve shows the 
average and was fitted using an exponential growth function.  This shows that 8OG-G4 has faster 
binding kinetics than G4mut for all probe lengths.   
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Figure 9. POT1 accessibility by construct. (A) Graph based on average and standard error of 3 
separate runs.  (B) Table showing % accessibility for each run and values for the average and 
standard error.  (C) Equation used to calculate POT1 accessibility.  Results indicate that single 
base substitution mutant has greater accessibility than 8OG, which in turn has greater 
accessibility than control construct. 
 
 
 
 
 
% 𝑎𝑐𝑐𝑒𝑠𝑠𝑖𝑏𝑖𝑙𝑖𝑡𝑦
𝐷𝑁𝐴
=
 ∑ 𝐹𝑅𝐸𝑇(𝐷𝑁𝐴+𝑃𝑂𝑇1) − 𝐹𝑅𝐸𝑇𝐷𝑁𝐴∆ <0  
∑ 𝐹𝑅𝐸𝑇𝐷𝑁𝐴∆ <0
× 100%, 
  𝑤ℎ𝑒𝑟𝑒 ∆ = 𝐹𝑅𝐸𝑇(𝐷𝑁𝐴+𝑃𝑂𝑇1) − 𝐹𝑅𝐸𝑇𝐷𝑁𝐴 
A 
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Figure 10. POT1 binding time for G4 length constructs. (A) Graph of POT1 binding time 
based on average and standard error of data points of n counts as indicated by table below.  (B) 
Dwell time distribution fitted with exponential decay function of POT1 binding time and half-
life based on calculations for G4mut (top) and 8OG-G4 (bottom).  Findings show that 8OG-G4 
binds faster than G4mut, and that both are much faster than G4. 
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Figure 11. Cumulative distribution curve of POT1 binding time. (A) Cumulative distribution 
curve was adjusted for % of bound molecules using the average % accessibility calculated.  (B) 
Inset of the cumulative distribution curve showing the first two minutes of POT1 binding. (C) 
Table of % accessibility for experiments from which data points for dwell time were taken.  
These results indicate that 8OG-G4 binds faster than G4mut, but plateaus at a smaller % of 
bound molecules than G4mut. 
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